433 related articles for article (PubMed ID: 16412800)
41. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
[TBL] [Abstract][Full Text] [Related]
42. The effect of carvedilol on B-type natriuretic peptide and cardiac function in patients with heart failure and persistent atrial fibrillation.
Khand AU; Chew PG; Douglas H; Jones J; Jan A; Cleland JG
Cardiology; 2015; 130(3):153-8. PubMed ID: 25660493
[TBL] [Abstract][Full Text] [Related]
43. THE SAFETY AND EFFICACY OF AMIODARONE AND CARVEDILOL COMBINATION IN TREATMENT OF PATIENTS WITH SEVERE CARDIAC RHYTHM DISORDERS.
Tsetskhladze E; Khintibidze I
Georgian Med News; 2017 Jun; (267):53-57. PubMed ID: 28726654
[TBL] [Abstract][Full Text] [Related]
44. Carvedilol: use in chronic heart failure.
Doughty RN; White HD
Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454
[TBL] [Abstract][Full Text] [Related]
45. Left ventricular dysfunction in atrial fibrillation: restoration of sinus rhythm by the Cox-maze procedure significantly improves systolic function and functional status.
Stulak JM; Dearani JA; Daly RC; Zehr KJ; Sundt TM; Schaff HV
Ann Thorac Surg; 2006 Aug; 82(2):494-500; discussion 500-1. PubMed ID: 16863752
[TBL] [Abstract][Full Text] [Related]
46. Effect of carvedilol on survival in severe chronic heart failure.
Packer M; Coats AJ; Fowler MB; Katus HA; Krum H; Mohacsi P; Rouleau JL; Tendera M; Castaigne A; Roecker EB; Schultz MK; DeMets DL;
N Engl J Med; 2001 May; 344(22):1651-8. PubMed ID: 11386263
[TBL] [Abstract][Full Text] [Related]
47. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol.
Capomolla S; Febo O; Gnemmi M; Riccardi G; Opasich C; Caporotondi A; Mortara A; Pinna GD; Cobelli F
Am Heart J; 2000 Apr; 139(4):596-608. PubMed ID: 10740140
[TBL] [Abstract][Full Text] [Related]
48. Comparison of the efficacy of metoprolol and carvedilol for preventing atrial fibrillation after coronary bypass surgery.
Acikel S; Bozbas H; Gultekin B; Aydinalp A; Saritas B; Bal U; Yildirir A; Muderrisoglu H; Sezgin A; Ozin B
Int J Cardiol; 2008 May; 126(1):108-13. PubMed ID: 17499863
[TBL] [Abstract][Full Text] [Related]
49. Left ventricular systolic dysfunction in a cardiac transplant recipient treated with carvedilol.
Gardner RS; McGowan J; McDonagh TA
Eur J Heart Fail; 2002 Jun; 4(3):377-9. PubMed ID: 12034165
[TBL] [Abstract][Full Text] [Related]
50. Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection.
Chin BS; Gibbs CR; Blann AD; Lip GY
Clin Sci (Lond); 2003 Oct; 105(4):507-12. PubMed ID: 12841846
[TBL] [Abstract][Full Text] [Related]
51. Comparative effects of nebivolol and carvedilol on left ventricular diastolic function in older heart failure patients with preserved ejection fraction: study protocol for a randomized controlled trial.
Park K; Park TH
Trials; 2016 Nov; 17(1):530. PubMed ID: 27809882
[TBL] [Abstract][Full Text] [Related]
52. Tolerability of beta-blocker initiation and titration with bisoprolol and carvedilol in congestive heart failure -- a randomized comparison.
Galatius S; Gustafsson F; Atar D; Hildebrandt PR
Cardiology; 2004; 102(3):160-5. PubMed ID: 15334027
[TBL] [Abstract][Full Text] [Related]
53. Rapid carvedilol up-titration in hospitalized patients with left ventricular systolic dysfunction--data from the Carvedilol in Hospital: Up-titration Limits after Acute Patients Admission registry.
Martínez-Sellés M; Datino T; Alhama M; Barrueco N; Castillo I; Fernández-Avilés F
J Cardiovasc Med (Hagerstown); 2010 May; 11(5):352-8. PubMed ID: 20154635
[TBL] [Abstract][Full Text] [Related]
54. The impact of baseline HR and BP on the tolerability of carvedilol in the elderly: the COLA (Carvedilol Open Label Assessment) II Study.
Macdonald PS; Hill J; Krum H;
Am J Cardiovasc Drugs; 2006; 6(6):401-5. PubMed ID: 17192130
[TBL] [Abstract][Full Text] [Related]
55. The comparative effects of long-term carvedilol versus bisoprolol therapy on QT dispersion in patients with chronic heart failure.
Aygul N; Ozdemir K; Duzenli MA; Aygul MU
Cardiology; 2009; 112(3):168-73. PubMed ID: 18654081
[TBL] [Abstract][Full Text] [Related]
56. Carvedilol reduces aldosterone release in systolic heart failure.
Aggarwal A; Wong J; Campbell DJ
Heart Lung Circ; 2006 Oct; 15(5):306-9. PubMed ID: 16935558
[TBL] [Abstract][Full Text] [Related]
57. Tolerability of carvedilol in heart failure: clinical trials experience.
Krum H
Am J Cardiol; 2004 May; 93(9A):58B-63B. PubMed ID: 15144940
[TBL] [Abstract][Full Text] [Related]
58. A pilot study on the effects of carvedilol on right ventricular remodelling and exercise tolerance in patients with systemic right ventricle.
Giardini A; Lovato L; Donti A; Formigari R; Gargiulo G; Picchio FM; Fattori R
Int J Cardiol; 2007 Jan; 114(2):241-6. PubMed ID: 21882492
[TBL] [Abstract][Full Text] [Related]
59. Betablockers in heart failure: Carvedilol Safety Assessment (CASA 2-trial).
Rickli H; Steiner S; Müller K; Hess OM
Eur J Heart Fail; 2004 Oct; 6(6):761-8. PubMed ID: 15542414
[TBL] [Abstract][Full Text] [Related]
60. Carvedilol in the failing heart.
Lombardi WL; Gilbert EM
Clin Cardiol; 2001 Dec; 24(12):757-66. PubMed ID: 11768738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
